Alzheimer’s disease involves amyloid beta plaques outside brain cells and tau tangles within them. These protein changes disrupt communication between neurons and contribute to gradual cell loss, especially in memory-related regions such as the hippocampus—helping explain the slow decline in thinking and memory.

Multiple Choice

Which brain changes are associated with Alzheimer's disease?

Alzheimer's disease is defined by two hallmark brain changes: extracellular amyloid beta plaques and intracellular neurofibrillary tangles made of hyperphosphorylated tau. These abnormal protein accumulations disrupt synaptic function and lead to progressive neuronal loss, especially in memory-related regions like the hippocampus and cerebral cortex, producing the characteristic gradual cognitive decline. Other options describe different conditions—demyelination with gliosis occurs in diseases such as multiple sclerosis; meningitis involves inflammation of the meninges; neuronal loss from an acute infection points to encephalitis. The combination of amyloid plaques and tau tangles is the best match for the changes seen in Alzheimer's disease.

Alzheimer’s Disease: The Brain Changes Behind Memory Loss

Alzheimer’s disease changes the brain gradually, often long before its effects become clear in daily life. Two changes are especially closely linked to the disease: amyloid plaques that build up between brain cells, and neurofibrillary tangles that form inside them. These abnormal protein deposits interfere with how brain cells communicate and, over time, contribute to cell damage and loss.

The story is more complex than a simple buildup of “bad proteins.” Alzheimer’s affects networks across the brain, and no single change explains every symptom or every person’s experience. Still, plaques and tangles offer a useful starting point for understanding why memory, language, judgment, and independence can slowly become harder to manage.

Two proteins, two places

Amyloid plaques form outside nerve cells, also called neurons. They contain fragments of a protein known as amyloid beta. The brain normally makes and clears these fragments, but in Alzheimer’s disease, amyloid beta can collect into clumps. These deposits may disrupt communication between neurons and trigger a harmful response in nearby brain tissue.

Neurofibrillary tangles form inside neurons. They’re made from tau, a protein that normally helps support the cell’s internal structure and transport system. In Alzheimer’s, tau becomes abnormally changed—often described as hyperphosphorylated—and no longer works as it should. It clumps into tangled fibers inside the cell.

A simple comparison may help: picture a busy railway station. Amyloid buildup can obstruct the shared spaces between platforms, while damaged tau jams the tracks inside individual trains. The brain’s transport and messaging systems begin to falter. The analogy isn’t perfect, but it captures a key point: the two changes occur in different places and can disrupt different parts of a neuron’s work.

From protein buildup to lost connections

Neurons send signals to one another across tiny gaps called synapses. These connections allow brain regions to share information, form memories, and guide behavior. When synapses are damaged, messages may arrive less clearly—or not at all.

As Alzheimer’s progresses, neurons can become injured and die. Brain tissue may shrink, especially in areas involved in memory and higher thinking. The hippocampus, which helps form and organize new memories, is often affected early. Changes can later spread through parts of the cerebral cortex, which supports language, reasoning, recognition, and many other functions.

That progression helps explain why early symptoms often involve recent events. Someone may remember a childhood home in rich detail but struggle to recall what they had for lunch. This isn’t simply ordinary forgetfulness. The issue may be that the brain has trouble storing new information in the first place.

Over time, other abilities can change as well. A person may have difficulty finding familiar words, following a conversation, handling bills, or recognizing a place they know. Some people become more anxious or withdrawn; others may show changes in mood or judgment. Symptoms vary, because Alzheimer’s does not affect every brain in exactly the same pattern.

Why plaques and tangles matter—but don’t tell the whole story

Amyloid plaques and tau tangles are the hallmark brain changes associated with Alzheimer’s disease. They’re important to scientific research and to the way clinicians understand the disease. Yet they don’t act like a simple on-off switch.

Some people have amyloid deposits without clear symptoms of dementia. Other factors—including the location and spread of tau, the health of blood vessels, inflammation, age, and a person’s broader medical history—may influence how symptoms develop. Researchers are still studying how these processes interact. In other words, plaques matter, but a person’s experience can’t be reduced to one stain on a brain scan.

The timing also complicates the picture. Biological changes may begin years before noticeable problems with memory or thinking. That gap is one reason Alzheimer’s can feel as though it appeared suddenly to families, even though changes in the brain may have been unfolding quietly for a long time.

Not every brain disorder works this way

It helps to distinguish Alzheimer’s from other neurological conditions, since many can affect thinking or movement.

In multiple sclerosis, the immune system damages myelin, the protective covering around nerve fibers in the central nervous system. That damage may leave areas of scarring, called gliosis, and can interrupt signals along affected nerves. This differs from the characteristic amyloid plaques and tau tangles associated with Alzheimer’s.

Meningitis involves inflammation of the meninges, the membranes that surround the brain and spinal cord. It can result from infections or other causes and may develop quickly. Encephalitis, by contrast, is inflammation of brain tissue itself, often linked to an infection or immune reaction. These conditions can cause serious neurological symptoms, but they are not the same process as the gradual changes typical of Alzheimer’s disease.

The distinction matters because similar symptoms can have very different causes. Confusion, memory trouble, or personality changes deserve careful medical assessment; they don’t point to one diagnosis on their own.

How clinicians build a clearer picture

A clinician usually considers several kinds of information when assessing memory and thinking changes. This may include a conversation about symptoms and daily function, a medical history, a physical and neurological examination, and cognitive assessments. Blood tests can help identify other contributors, such as thyroid problems or vitamin deficiencies.

Brain imaging may help rule out other causes or show patterns of change. In some settings, tests that detect amyloid or tau may also contribute to diagnosis. These tools are interpreted alongside a person’s symptoms and circumstances rather than in isolation. A scan or laboratory result is one part of a larger picture.

That broader view is important because memory problems can arise from many sources, including medication effects, depression, sleep disorders, infections, or vascular disease. Some causes can be treated, which makes a careful evaluation worthwhile.

Care reaches beyond the biology

There is no single response to Alzheimer’s that fits everyone. Care may include medicines that help manage symptoms for some people, support for sleep and mood, and routines that make everyday tasks easier. A calm, familiar environment can help reduce stress, particularly when changes in memory or orientation become more pronounced.

Support for family members and caregivers matters, too. Small adjustments—clear labels, a steady daily rhythm, or fewer competing noises during conversation—can make ordinary moments feel less demanding. These aren’t grand gestures. Often, it’s the quiet details that help someone feel safe and respected.

Research continues to examine amyloid, tau, inflammation, and the health of brain networks. That work has already sharpened understanding of Alzheimer’s, but many questions remain. The central idea is clear: plaques outside neurons and tangles inside them are signature changes, and they contribute to damage in the brain’s communication systems. Understanding that biology can help make sense of the gradual changes people experience—and support care that sees the person, not just the disease.